Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells

Biochemical and Biophysical Research Communications

Volumn 360, Issue 2, 2007, Pages 346-351

  Islam, Shamima ^a   Hassan, Ferdaus ^a   Tumurkhuu, Gantsetseg ^a   Dagvadorj, Jargalsaikhan ^a   Koide, Naoki ^a   Naiki, Yoshikazu ^a   Mori, Isamu ^a   Yoshida, Tomoaki ^a   Yokochi, Takashi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Jun N terminal kinase 1 2 (JNK1 2); Lipopolysaccharide; Macrophage colony stimulating factor; Osteoclast; Receptor activator of nuclear factor B ligand (RANKL); Tartrate resistant acid phosphatase (TRAP); TNF

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCIUM PHOSPHATE; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; FILM; GIANT CELL; MACROPHAGE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL;

ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; ESCHERICHIA COLI; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; OSTEOCLASTS;

BACTERIA (MICROORGANISMS); MURINAE;

EID: 34447109965     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.023     Document Type: Article

References (31)

1. Roodman G.D. Cell biology of the osteoclast. Exp. Hematol. 27 (1999) 1229-1241
2. Chambers T.J. Regulation of the differentiation and function of osteoclasts. J. Pathol. 192 (2000) 4-13
3. Teitelbaum S.L. Bone resorption by osteoclasts. Science 289 (2000) 1504-1508
4. Suda T., Kobayashi K., Jimi E., Udagawa N., and Takahashi N. The molecular basis of osteoclast differentiation and activation. Novartis Found. Symp. 232 (2001) 235-247
5. Suda T., Takahashi N., and Martin T.J. Modulation of osteoclast differentiation. Endocr. Rev. 13 (1992) 66-80
6. Nair S.P., Meghji S., Wilson M., Reddi K., White P., and Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect. Immun. 64 (1996) 2371-2380
7. Quinn J.M., and Gillespie M.T. Modulation of osteoclast formation. Biochem. Biophys. Res. Commun. 328 (2005) 739-745
8. Teitelbaum S.L. Osteoclasts: what do they do and how do they do it?. Am. J. Pathol. 170 (2007) 427-435
9. Lam J., Takeshita S., Barker J.E., Kanagawa O., Ross F.P., and Teitelbaum S.L. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106 (2000) 1481-1488
10. Akatsu T., Takahashi N., Debari K., Morita I., Murota S., Nagata N., Takatani O., and Suda T. Prostaglandins promote osteoclast like cell formation by a mechanism involving cyclic adenosine 3′,5′-monophosphate in mouse bone marrow cell cultures. J. Bone Miner. Res. 4 (1989) 29-35
11. 2 and the receptor Ep4 in osteoblasts. Life Sci. 78 (2006) 2012-2018
12. Islam S., Hassan F., Mu M.M., Ito H., Koide N., Mori I., Yoshida T., and Yokochi T. Piceatannol prevents lipopolysaccharide (LPS)-induced nitric oxide (NO) production and nuclear factor (NF)-kappaB activation by inhibiting IkappaB kinase (IKK). Microbiol. Immunol. 48 (2004) 729-736
13. Hammarstrom L.E., Hanker J.S., and Toverud S.U. Cellular differences in acid phosphatase isoenzymes in bone and teeth. Clin. Orthop. Relat. Res. 78 (1971) 151-167
14. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 34 (1982) 285-290
15. Anderson H.C. Mechanism of mineral formation in bone. Lab. Invest. 60 (1989) 320-330
16. Matsumoto M., Sudo T., Saito T., Osada H., and Tsujimoto M. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J. Biol. Chem. 275 (2000) 31155-31161
17. Miyazaki T., Katagiri H., Kanegae Y., Takayanagi H., Sawada Y., Yamamoto A., Pando M.P., Asano T., Verma I.M., Oda H., Nakamura K., and Tanaka S. Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J. Cell Biol. 148 (2000) 333-342
18. Zhang Y.H., Heulsmann A., Tondravi M.M., Mukherjee A., and Abu-Amer Y. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J. Biol. Chem. 276 (2001) 563-568
19. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D., Leonardi A., Tran T., Boyce B.F., and Siebenlist U. Requirement of NF-kappaB in osteoclast and B-cell development. Genes Dev. 11 (1997) 3482-3496
20. Sugatani T., Alvarez U., and Hruska K.A. PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility. J. Biol. Chem. 278 (2003) 5001-5008
21. Toyomura T., Murata Y., Yamamoto A., Oka T., Sun-Wada G.H., Wada Y., and Futai M. From lysosomes to the plasma membrane: localization of vacuolar-type H+-ATPase with the a3 isoform during osteoclast differentiation. J. Biol. Chem. 278 (2003) 22023-22030
22. Suda K., Woo J.T., Takami M., Sexton P.M., and Nagai K. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J. Cell. Physiol. 190 (2002) 101-108
23. Hotokezaka H., Sakai E., Ohara N., Hotokezaka Y., Gonzales C., Matsuo K., Fujimura Y., Yoshida N., and Nakayama K. Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan. J. Cell. Biochem. 101 (2007) 122-134
24. Azuma Y., Kaji K., Katogi R., Takeshita S., and Kudo A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275 (2000) 4858-4864
25. Takayanagi H., Kim S., and Taniguchi T. Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res. 4 (2002) 227-232
26. Yamamoto A., Miyazaki T., Kadono Y., Takayanagi H., Miura T., Nishina H., Katada T., Wakabayashi K., Oda H., Nakamura K., and Tanaka S. Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand. J. Bone Miner. Res. 17 (2002) 612-621
27. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., and Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3 (2002) 889-901
28. Kim H.H., Lee D.E., Shin J.N., Lee Y.S., Jeon Y.M., Chung C.H., Ni J., Kwon B.S., and Lee Z.H. Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase. FEBS Lett. 443 (1999) 297-302
29. Islam S., Hassan F., Tumurkhuu G., Ito H., Koide N., Mori I., Yoshida T., and Yokochi T. 5-Fluorouracil prevents lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells by inhibiting Akt-dependent nuclear factor-kappaB activation. Cancer Chemother. Pharmacol. 59 (2007) 227-233
30. Ishizuka T., Terada N., Gerwins P., et al. Mast cell tumor necrosis factor production is regulated by MEK kinases. Proc. Natl. Acad. Sci. USA 94 (1997) 6358-6363
31. Bennett B.L., Sasaki D.T., Murray B.W., et al. SP600125, an anthrapyrazolone inhibitor of JUN N-terminal kinase. Proc. Natl. Acad. Sci. USA 98 (1997) 13681-13686